Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2017 / Cilt: 26 - Sayı: 1

Obesity and Kidney Disease: Hidden Consequences of the Epidemic

Obezite ve Böbrek Hastalığı: Epideminin Gizli Sonuçları

Pages
1–10
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This year the World Kidney Day promotes education on the harmful consequences of obesity and its association with kidney disease, advocating a healthy lifestyle and health policy measures that make preventive behaviors an affordable option.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Obesity has become a worldwide epidemic, and its prevalence has been projected to grow by 40% in the next decade.
📊
Key Findings & Data:In individuals affected by obesity, compensatory hyperfiltration occurs to meet the heightened metabolic demands of the increased body weight.
💡
Conclusion & Impact:This year the World Kidney Day promotes education on the harmful consequences of obesity and its association with kidney disease, advocating a healthy lifestyle and health policy measures that make preventive behaviors an affordable option.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Obesity has become a worldwide epidemic, and its prevalence has been projected to grow by 40% in the next decade. This increasing prevalence has implications for the risk of diabetes, cardiovascular disease and also for Chronic Kidney Disease. A high body mass index is one of the strongest risk factors for new-onset Chronic Kidney Disease. In individuals affected by obesity, compensatory hyperfiltration occurs to meet the heightened metabolic demands of the increased body weight. The increase in intraglomerular pressure can damage the kidneys and raise the risk of developing Chronic Kidney Disease in the long-term. The incidence of obesity-related glomerulopathy has increased tenfold in recent years. Obesity has also been shown to be a risk factor for nephrolithiasis, and for a number of malignancies including kidney cancer. This year the World Kidney Day promotes education on the harmful consequences of obesity and its association with kidney disease, advocating a healthy lifestyle and health policy measures that make preventive behaviors an affordable option.

Özet

Obezite dünya çapında bir epidemi haline gelmiştir ve prevalansının gelecek 10 yılda %40 artması beklenmektedir. Bu artan prevalansın diyabet, kardiyovasküler hastalık ve ayrıca Kronik Böbrek Hastalığı açısından etkileri olabilir. Yüksek bir vücut kitle indeksi yeni oluşan Kronik Böbrek Hastalığı açısından en güçlü risk faktörlerinden biridir. Obeziteden etkilenen kişilerde artmış vücut ağırlığının artmış metabolik taleplerini karşılamak üzere dengeleyici bir hiperfiltrasyon oluşur. İntraglomerüler basınç artışı böbreklere zarar verebilir ve uzun dönemde Kronik Böbrek Hastalığı gelişme riskini artırabilir. Obeziteyle ilişkili glomerülopati insidansı son yıllarda on kat artmıştır. Obezitenin nefrolitiazis ve ayrıca böbrek kanseri dahil çeşitli malignansiler için bir risk faktörü olduğu gösterilmiştir. Bu yıl Dünya Böbrek Günü obezitenin zararlı sonuçları ve böbrek hastalığı ile ilişkisi konusunda eğitim ile birlikte önleyici davranışı makul fiyatlı bir seçenek haline getirebilecek sağlıklı bir yaşam tarzıyla sağlık politikası önlemlerini desteklemektedir.

🔖

Cite This Article

KOVESDY, C. P., ZOCCALİ, C. (2022). Obesity and Kidney Disease: Hidden Consequences of the Epidemic. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 26 - Sayı: 1, 1–10. https://ajindex.com/articles/636133

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. l. Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, Cohen A, Delwiche K, Estep K, Frostad JJ, Astha KC, Kyu HH, MoradiLakeh M, Ng M, Slepak EL, Thomas BA, Wagner J, Aasvang GM, Abbafati C, Abbasoglu OA, Abd-Allah F, Abera SF, Aboyans V, Abraham B, Abraham JP, Abubakar I, Abu-Rmeileh NM, Aburto TC, Achoki T, Adelekan A, Adofo K, Adou AK, Adsuar JC, Afshin A, Agardh EE, A1 Khabouri MJ, Al Lami FH, Alam SS, Alasfoor D, Albittar MI, Alegretti MA, Aleman AV, Alemu ZA, AlfonsoCristancho R, Alhabib S, Ali R, Ali MK, Alla F, Allebeck P, Allen PJ Alsharif U, Alvarez E, Alvis-Guzman N, Amankwaa AA, Amare AT, Ameh EA, Ameli O, Amini H, Ammar W, Anderson BO, Antonio CA, Anwari P, Argeseanu CS, Arnlov J, Arsenijevic VS, Artaman A, Asghar RJ, Assadi R, Atkins LS, Atkinson C, Avila MA, Awuah B, Badawi A, Bahit MC, Bakfalouni T, Balakrishnan K, Balalla S, Balu RK, Banerjee A, Barber RM, Barker-C0110 SL, Barquera S, Barregard L, Barrero LH, Barrientos-Gutierrez T, Basto-Abreu AC, Basu A, Basu S, Basulaiman MO, Batis RC, Beardsley J, Bedi N, Bekele T, Bell ML, Benjet C, Bennett DA, Benzian H, Bernabe E, Beyene TJ, Bhala N, Bhalla A, Bhutta ZA, Bikbov B, Bin Abdulhak AA, Blore JD, Blyth FM, Bohensky MA, Bora BB, Borges G, Bornstein NM, Bose D, Boufous S, Bourne RR, Brainin M, Brazinova A, Breitborde NJ, Brenner H, Briggs AD, Broday DM, Brooks PM, Bruce NG, Brugha TS, Brunekreef B, Buchbinder R, Bui LN, Bukhman G, Bulloch AG, Burch M, Burney PG, Campos-Nonato IR, Campuzano JC, Cantoral AJ, Caravanos J, Cardenas R, Cardis E, Carpenter DO, Caso V, Castaneda-Orjuela CA, Castro RE, Catala-Lopez F, Cavalleri F, Cavlin A, Chadha VK, Chang JC, Charlson FJ Chen H, Chen W, Chen Z, Chiang PP, Chimed-Ochir O, Chowdhury R, Christophi CA, Chuang TW, Chugh SS, Cirillo M, Classen TK, Colistro V, Colomar M, Colquhoun SM, Contreras AG, Cooper C, Cooperrider K, Cooper LT, Coresh J, Courville KJ Criqui MH, Cuevas-Nasu L, Damsere-Derry J, Danawi H, Dandona L, Dandona R, Dargan PI, Davis A, Davitoiu DV, Dayama A, de Castro EF, De lC-G, V, De LD, de LG, Degenhardt L, del Pozo-Cruz B, Dellavalle RP, Deribe K, Derrett S, Des Jarlais DC, Dessalegn M, deVeber GA, Devries KM, Dharrnaratne SD, Dherani MK, Dicker D, Ding EL, Dokova K, Dorsey ER, Driscoll TR, Duan L, Durrani AM, Ebel BE, Ellenbogen RG, Elshrek YM, Endres M, Errnakov SP, Erskine HE, Eshrati B, Esteghamati A, Fahimi S, Faraon EJ, Farzadfar F, Fay DF, Fei gin VL, Fei gl AB Fereshtehne